Health and Healthcare
63 Articles
Amarin Inc. (NASDAQ: AMRN) just went off the charts, literally. The company reported very solid Phase III study results this…
2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the…
Amarin Corporation plc (NASDAQ: AMRN) is indicated up 50% at $5.35, well above the $3.85 52-week high, after its AMR101…
Our top personal finance-related articles today. Your wallet will thank you later.